NO20021367L - Indolyl-3-glycosyl acid derivatives having therapeutically valuable properties - Google Patents

Indolyl-3-glycosyl acid derivatives having therapeutically valuable properties

Info

Publication number
NO20021367L
NO20021367L NO20021367A NO20021367A NO20021367L NO 20021367 L NO20021367 L NO 20021367L NO 20021367 A NO20021367 A NO 20021367A NO 20021367 A NO20021367 A NO 20021367A NO 20021367 L NO20021367 L NO 20021367L
Authority
NO
Norway
Prior art keywords
indolyl
acid derivatives
therapeutically valuable
valuable properties
glycosyl acid
Prior art date
Application number
NO20021367A
Other languages
Norwegian (no)
Other versions
NO20021367D0 (en
NO322614B1 (en
Inventor
Bernd Nickel
Thomas Klenner
Gerald Bacher
Thomas Beckers
Peter Emig
Juergen Engel
Erik Bruyneel
Guenter Kam
Kirsten Peters
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19946301A external-priority patent/DE19946301A1/en
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of NO20021367D0 publication Critical patent/NO20021367D0/en
Publication of NO20021367L publication Critical patent/NO20021367L/en
Publication of NO322614B1 publication Critical patent/NO322614B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021367A 1999-09-28 2002-03-19 Indolyl-3-glycosyl acid derivatives having therapeutically valuable properties NO322614B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19946301A DE19946301A1 (en) 1998-04-02 1999-09-28 Antitumor agents and angiogenesis inhibitors having low neurotoxicity, comprise indole-3-glyoxylamide derivatives, are effective against resistant and metastasis-forming carcinomas
PCT/EP2000/009390 WO2001022954A2 (en) 1999-09-28 2000-09-26 Indolyl-3-glyoxylic acid derivatives serving as antitumor agents

Publications (3)

Publication Number Publication Date
NO20021367D0 NO20021367D0 (en) 2002-03-19
NO20021367L true NO20021367L (en) 2002-05-22
NO322614B1 NO322614B1 (en) 2006-11-06

Family

ID=7923485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021367A NO322614B1 (en) 1999-09-28 2002-03-19 Indolyl-3-glycosyl acid derivatives having therapeutically valuable properties

Country Status (32)

Country Link
EP (1) EP1218006B1 (en)
JP (1) JP2003510274A (en)
KR (1) KR100759242B1 (en)
CN (1) CN1301712C (en)
AR (1) AR025885A1 (en)
AT (1) ATE459356T1 (en)
AU (1) AU783436B2 (en)
BG (1) BG106639A (en)
BR (1) BR0014378A (en)
CA (1) CA2386069C (en)
CZ (1) CZ303246B6 (en)
DE (1) DE50015879D1 (en)
DZ (1) DZ3196A1 (en)
EE (1) EE200200169A (en)
ES (1) ES2342042T3 (en)
GE (1) GEP20043250B (en)
HK (1) HK1048941B (en)
HR (1) HRP20020369A2 (en)
HU (1) HUP0202788A3 (en)
IL (2) IL148670A0 (en)
IS (1) IS6319A (en)
MX (1) MXPA02002824A (en)
NO (1) NO322614B1 (en)
NZ (1) NZ517988A (en)
PL (1) PL199576B1 (en)
RS (1) RS51302B (en)
RU (1) RU2282444C2 (en)
SK (1) SK287533B6 (en)
TW (1) TWI269654B (en)
UA (1) UA75872C2 (en)
WO (1) WO2001022954A2 (en)
ZA (1) ZA200202556B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (en) * 1999-12-23 2001-06-28 Asta Medica Ag New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
DE10037310A1 (en) * 2000-07-28 2002-02-07 Asta Medica Ag New indole derivatives and their use as medicines
EP1484329A1 (en) * 2003-06-06 2004-12-08 Zentaris GmbH Indole derivatives with apoptosis inducing activity
BRPI0410998A (en) * 2003-06-05 2006-07-04 Zentaris Gmbh indole derivatives with apoptosis inducing effect
EP1595878A1 (en) * 2004-05-15 2005-11-16 Zentaris GmbH Indole derivatives with apoptosis inducing activity
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
EP1751115A4 (en) * 2004-05-23 2010-10-20 Gerard M Housey THERAMUTEINE MODULATORS
AU2005304952B2 (en) * 2004-11-08 2013-04-04 Baxter Healthcare S.A. Nanoparticulate compositions of tubulin inhibitors
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
WO2006073973A2 (en) 2004-12-31 2006-07-13 Reddy Us Therapeutics, Inc. Novel benzylamine derivatives as cetp inhibitors
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
EP2091532A1 (en) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
US9199967B2 (en) 2011-08-18 2015-12-01 Dr. Reddy's Laboratories Ltd. Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors
MX352074B (en) 2011-09-27 2017-11-08 Dr Reddys Laboratories Ltd 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis.
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
US10201623B2 (en) 2013-03-15 2019-02-12 Memorial Sloan Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
CN109111501B (en) * 2017-06-23 2022-04-22 首都医科大学 Fatty amino acid-modified indoleethanol derivatives, their synthesis, activities and applications
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4128089A (en) 1988-09-15 1990-03-22 Rorer International (Overseas) Inc. Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
RU2047603C1 (en) * 1991-12-09 1995-11-10 Матвей Абрамович Рехтер 1-alkyl-2-acylindoles and methods of their synthesis
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
AU671865B2 (en) * 1992-10-20 1996-09-12 Toray Industries, Inc. Eosinophil infiltration inhibitor
DE19636150A1 (en) * 1996-09-06 1998-03-12 Asta Medica Ag N-substituted indole-3-glyoxylamides with antiasthmatic, antiallergic and immunosuppressive / immunomodulating effects
CA2286038A1 (en) 1997-04-08 1998-10-15 Banyu Pharmaceutical Co., Ltd. Cancerous metastasis-associated gene
EE200000488A (en) * 1998-02-25 2002-02-15 Genetics Institute, Inc. Phospholipase enzyme inhibitors and pharmaceutical compositions
WO1999046237A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases
DE19814838C2 (en) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylic acid derivatives with anti-tumor effects
TR200003130T2 (en) * 1998-04-28 2001-01-22 Arzneimittelwerk Dresden Gmbh Novel hydroxyindoles, processes for their use and preparation as phosphodiesterase 4 inhibitors
JP2000239252A (en) * 1999-02-16 2000-09-05 Mitsubishi Chemicals Corp Indole derivatives
AU4834200A (en) * 1999-05-10 2000-11-21 Protarga, Inc. Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof

Also Published As

Publication number Publication date
PL199576B1 (en) 2008-10-31
EP1218006B1 (en) 2010-03-03
EE200200169A (en) 2003-04-15
DZ3196A1 (en) 2001-04-05
KR100759242B1 (en) 2007-09-18
JP2003510274A (en) 2003-03-18
ZA200202556B (en) 2003-08-27
HK1048941A1 (en) 2003-04-25
CA2386069A1 (en) 2001-04-05
MXPA02002824A (en) 2003-07-21
NO20021367D0 (en) 2002-03-19
RU2282444C2 (en) 2006-08-27
IL148670A (en) 2009-09-01
SK287533B6 (en) 2011-01-04
HUP0202788A3 (en) 2003-02-28
UA75872C2 (en) 2006-06-15
CZ20021005A3 (en) 2004-01-14
CZ303246B6 (en) 2012-06-20
BG106639A (en) 2002-12-29
IL148670A0 (en) 2002-09-12
CA2386069C (en) 2012-08-14
EP1218006A2 (en) 2002-07-03
GEP20043250B (en) 2004-06-25
CN1376064A (en) 2002-10-23
AU7782900A (en) 2001-04-30
HRP20020369A2 (en) 2004-12-31
ES2342042T3 (en) 2010-07-01
DE50015879D1 (en) 2010-04-15
KR20030019295A (en) 2003-03-06
HUP0202788A2 (en) 2003-01-28
WO2001022954A2 (en) 2001-04-05
AR025885A1 (en) 2002-12-18
HK1048941B (en) 2007-09-21
ATE459356T1 (en) 2010-03-15
BR0014378A (en) 2003-07-29
AU783436B2 (en) 2005-10-27
YU22702A (en) 2004-12-31
TWI269654B (en) 2007-01-01
IS6319A (en) 2002-03-21
WO2001022954A3 (en) 2002-03-28
NO322614B1 (en) 2006-11-06
RS51302B (en) 2010-12-31
PL364811A1 (en) 2004-12-13
SK4072002A3 (en) 2003-11-04
NZ517988A (en) 2004-10-29
CN1301712C (en) 2007-02-28

Similar Documents

Publication Publication Date Title
NO20021367L (en) Indolyl-3-glycosyl acid derivatives having therapeutically valuable properties
EE200000720A (en) Novel 3-aryl-2-hydroxypropanoic acid derivative (I)
ATE335404T1 (en) CHEWABLE CONFECT PRODUCT
NO20033969L (en) Triazole pyridines as anti-inflammatory agents
NO20014412D0 (en) Compounds useful as anti-inflammatory agents
NO20021239L (en) Pteridinones as kinase inhibitors
DK1261585T3 (en) Substituted indole-Mannich bases
EE200000717A (en) Novel 3-aryl-2-hydroxypropanoic acid derivative III
ATE419231T1 (en) MONO-SUBSTITUTED 3-PROPYL-GAMMA-AMINOBUTTERIC ACID
NO20022558D0 (en) 4-Carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
DE60011669D1 (en) VITAMIN-D ANALOGA
EE200400023A (en) New sulphonic acid derivatives
ATE261958T1 (en) PHENYLPIPERAZINYL DERIVATIVES
DK1202953T3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
NO20020596D0 (en) Arylsulfonamide-substituted hydroxamic acid derivatives
NO20016201D0 (en) Tienopyrimidines as phosphodiesterase inhibitors
ATE309220T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDROCINOLINE-2-CARBOXYLIC ACID DERIVATIVES
DE60022034D1 (en) LAST CONSTRUCTION
DK1165547T3 (en) Substituted benzoylpyrazoles as herbicides
NO20014587L (en) resorcinol derivative
NO20025542D0 (en) quinolonecarboxylic acid derivatives
TR200002831A3 (en) Quinolin-4-Il derivatives I
IT248130Y1 (en) FOOTWEAR STRUCTURE
NO20015380D0 (en) Tio-oxindole derivative
DK1183236T3 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees